Cardinal Health's CFO Moved $9.9 Million of Stock. Here's What Long-Term Investors Should Know

Cardinal Health's CFO Aaron Alt sold 42,000 shares worth $9.9 million on August 18, reducing his direct holdings to 20,495 shares. The sale occurred after the stock surged 57% over the past year. Despite the insider sale, the company maintains strong guidance with fiscal 2027 EPS projected at $12.40-$12.60 (13-15% growth), planned capital expenditures of $700 million, and at least $1 billion in share repurchases expected.

08/23/2026, 7:31 AM • The Motley Fool

Cardinal Health's Medical Segment Boss Sold $8 Million in Stock. Here's What to Know

Stephen M. Mason, CEO of Cardinal Health's GMPD Segment, sold 35,000 shares worth $8.3 million on August 18, reducing his direct holdings by 29%. While the stock has gained 57% over the past year, the Medical segment continues to face challenges with declining revenue and profit margins, with fiscal 2027 projections ranging from $200-220 million depending on geopolitical factors.

08/23/2026, 7:22 AM • The Motley Fool

Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened

Deborah Weitzman, CEO of Cardinal Health's PSS Segment, sold 7,354 shares for ~$1.7 million on August 18, 2026, but still increased her total stake by 47% after receiving performance units. Despite the sale, her direct holdings grew to 77,901 shares valued at $18.31 million. The Pharmaceutical and Specialty Solutions segment she leads showed strong performance with 6% revenue growth and 21% profit growth in Q4, with specialty business growing over 25% in fiscal 2026.

08/23/2026, 7:14 AM • The Motley Fool

The CIO of Cardinal Health Parted With 11,650 Shares. Here's Whether It Matters for Long-Term Investors

Cardinal Health's CIO Michelle Greene sold 11,650 shares worth $2.7 million at a weighted average price of $235.72, reducing her direct stake by roughly 16%. While the sale follows strong stock appreciation, the article notes that Greene sold more aggressively than other executives like the CEO and legal officer. The transaction occurred amid the company's August award cycle and comes as Cardinal Health guides lower adjusted free cash flow for fiscal 2027 despite record capital expenditures in technology and automation.

08/23/2026, 7:07 AM • The Motley Fool

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global gauze bandage rolls market is valued at USD 1.96 billion in 2025 and is projected to reach USD 3.19 billion by 2035, growing at a CAGR of 4.97%. Growth is driven by rising surgical procedures, aging populations, chronic wound management, and technological advancements in antimicrobial and bioactive gauze products. Key market segments include cotton gauze (largest share), surgical wounds (dominant application), and hospitals (primary end-user), with Asia Pacific expected to show the fastest growth.

07/03/2026, 12:30 AM • GlobeNewswire

[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - Exclusive Report by ZMR | Global Surgical Masks Market Size, Share, Trends Analysis Report

The global surgical masks market is projected to grow from USD 3.95 billion in 2024 to USD 6.76 billion by 2034 at a CAGR of 5.5%. Growth is driven by rising healthcare applications, infection control awareness, and surgical interventions, though environmental concerns about disposal and competition from alternative respirators pose challenges. Europe is expected to lead the market, while basic surgical masks will dominate the product segment.

06/08/2026, 7:00 AM • GlobeNewswire

Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.

05/08/2026, 4:47 AM • GlobeNewswire

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health's Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, payable on July 15, 2026 to shareholders of record as of July 1, 2026. The dividend will be paid out of the company's capital surplus.

05/05/2026, 4:40 PM • Benzinga

Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide

The Dow Jones surged 1.5% driven by industrial and healthcare stocks, while mega-cap tech faced pressure from concerns over AI capital spending. Meta and Microsoft declined on capex worries, but Alphabet gained on enterprise AI wins. Industrials like Caterpillar, Quanta Services, and Carrier rallied on data-center infrastructure demand. The S&P 500 gained 0.5% while the Nasdaq 100 remained flat.

04/30/2026, 1:09 PM • Benzinga

Why Is Cardinal Health Stock Sinking Thursday?

Cardinal Health reported mixed Q3 2026 earnings with an EPS beat of $3.17 vs. $2.79 consensus, but revenue missed at $60.94B vs. $61.70B expected. Despite raising full-year guidance and reporting strong operational performance, the stock fell 8.23% to $186.12, likely due to the revenue miss and flat performance in the medical products segment.

04/30/2026, 11:20 AM • Benzinga

Radiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand

The global radiopharmaceuticals market is projected to grow from USD 8.28 billion in 2026 to USD 15.21 billion by 2035, driven by rising cancer and cardiovascular disease incidence. North America dominates with 43.95% market share, while Asia-Pacific is expected to register the fastest growth. Therapeutic radiopharmaceuticals and Technetium-99m lead their respective segments, with hospitals and clinics as the primary end users.

04/24/2026, 9:57 AM • GlobeNewswire

Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032

The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward clinical roles, and bundled solution procurement strategies across hospitals, clinics, and long-term care facilities.

04/09/2026, 4:57 AM • GlobeNewswire

Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032

The biopharmaceutical third-party logistics market is expected to grow from $140.03 billion in 2025 to $384.23 billion by 2032, with a CAGR of 15.51%. Growth is driven by rising product complexity, regulatory scrutiny, cold chain integrity demands, and technological advancements in digital tracking and specialized handling for biologics and gene therapies.

04/09/2026, 4:49 AM • GlobeNewswire

3 Dividend Stocks With High Returns on Invested Capital

The article examines three high-ROIC dividend-paying stocks: MasterCard, which reported strong Q4 2025 earnings with 17.3% revenue growth and 19% annual EPS growth; Starbucks, showing accelerating comparable store sales growth to 4% with expansion opportunities in China; and Cardinal Health, a major drug distributor posting 18.6% revenue growth and 39 consecutive years of dividend increases.

03/31/2026, 4:45 PM • Investing

Global Medical Device Cleaning Market Poised for Strong Growth as Infection Control Mandates and Reprocessing Technologies Accelerate Adoption: Verified Market Research®

The global medical device cleaning market is projected to grow from USD 2.08 billion in 2024 to USD 3.74 billion by 2032, driven by escalating infection prevention requirements, expanding reusable device utilization, and technological advancements in automated reprocessing systems. However, high capital costs, complex regulatory obligations, and workforce training variability pose challenges to uniform adoption across regions.

02/27/2026, 10:55 AM • GlobeNewswire